Vedrana Reichenbach

595 total citations
15 papers, 481 citations indexed

About

Vedrana Reichenbach is a scholar working on Pharmacology, Hepatology and Epidemiology. According to data from OpenAlex, Vedrana Reichenbach has authored 15 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Hepatology and 5 papers in Epidemiology. Recurrent topics in Vedrana Reichenbach's work include Apelin-related biomedical research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Liver physiology and pathology (3 papers). Vedrana Reichenbach is often cited by papers focused on Apelin-related biomedical research (6 papers), Liver Disease Diagnosis and Treatment (4 papers) and Liver physiology and pathology (3 papers). Vedrana Reichenbach collaborates with scholars based in Spain, United States and Germany. Vedrana Reichenbach's co-authors include Wladimiro Jiménez, Gregori Casals, Guillermo Fernández‐Varo, Manuel Morales‐Ruiz, Pedro Melgar‐Lesmes, Denise Oró, Josefa Ros Velasco, Silvia Carvajal, Bernardino González de la Presa and Ramón Bataller and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Vedrana Reichenbach

15 papers receiving 471 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vedrana Reichenbach Spain 11 144 137 133 125 95 15 481
Jordi Ribera Spain 11 182 1.3× 160 1.2× 98 0.7× 10 0.1× 104 1.1× 16 464
Hans Ernst Germany 13 48 0.3× 29 0.2× 222 1.7× 48 0.4× 19 0.2× 22 476
Tadahiro Shinozawa Japan 14 171 1.2× 56 0.4× 115 0.9× 9 0.1× 13 0.1× 28 690
Vaishaali Natarajan United States 7 110 0.8× 63 0.5× 108 0.8× 6 0.0× 86 0.9× 8 421
Sayuri Nakamura Japan 11 55 0.4× 103 0.8× 49 0.4× 7 0.1× 16 0.2× 39 408
Xiaojun Cai China 13 10 0.1× 50 0.4× 55 0.4× 22 0.2× 40 0.4× 27 380
Qinglin Zhang China 10 12 0.1× 52 0.4× 54 0.4× 55 0.4× 9 0.1× 40 302
Dina H. Kassem Egypt 14 9 0.1× 117 0.9× 126 0.9× 28 0.2× 14 0.1× 32 587
Yiming Liu China 12 10 0.1× 118 0.9× 25 0.2× 25 0.2× 142 1.5× 32 546
Fen Zhang China 12 68 0.5× 74 0.5× 84 0.6× 9 0.1× 16 0.2× 21 389

Countries citing papers authored by Vedrana Reichenbach

Since Specialization
Citations

This map shows the geographic impact of Vedrana Reichenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vedrana Reichenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vedrana Reichenbach more than expected).

Fields of papers citing papers by Vedrana Reichenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vedrana Reichenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vedrana Reichenbach. The network helps show where Vedrana Reichenbach may publish in the future.

Co-authorship network of co-authors of Vedrana Reichenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Vedrana Reichenbach. A scholar is included among the top collaborators of Vedrana Reichenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vedrana Reichenbach. Vedrana Reichenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Perramón, Meritxell, Silvia Carvajal, Vedrana Reichenbach, et al.. (2022). The pituitary tumour‐transforming gene 1/delta‐like homologue 1 pathway plays a key role in liver fibrogenesis. Liver International. 42(3). 651–662. 8 indexed citations
2.
Martí, Josep, Wladimiro Jiménez, Vedrana Reichenbach, et al.. (2017). Prognostic Prediction by Liver Tissue Proteomic Profiling in Patients with Colorectal Liver Metastases. Future Oncology. 13(10). 875–882. 2 indexed citations
3.
Fernández‐Varo, Guillermo, Denise Oró, Edward E. Cable, et al.. (2015). Vasopressin 1a receptor partial agonism increases sodium excretion and reduces portal hypertension and ascites in cirrhotic rats. Hepatology. 63(1). 207–216. 14 indexed citations
4.
Oró, Denise, Guillermo Fernández‐Varo, Eudald Casals, et al.. (2015). Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis. Journal of Hepatology. 64(3). 691–698. 172 indexed citations
5.
Fabregat, Andreu, Josep Marcos, Rosa Ventura, et al.. (2014). Formation of Δ1 and Δ6 testosterone metabolites by human hepatocytes. Steroids. 95. 66–72. 11 indexed citations
6.
Pauta, Montse, Jordi Ribera, Pedro Melgar‐Lesmes, et al.. (2014). Overexpression of angiopoietin‐2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition. Liver International. 35(4). 1383–1392. 30 indexed citations
7.
Crespo, Gonzalo, Vedrana Reichenbach, Xavier Forns, et al.. (2014). Lack of a 5.9 kDa Peptide C-Terminal Fragment of Fibrinogen α Chain Precedes Fibrosis Progression in Patients with Liver Disease. PLoS ONE. 9(10). e109254–e109254. 10 indexed citations
8.
Casals, Gregori, Guillermo Fernández‐Varo, Pedro Melgar‐Lesmes, et al.. (2013). Factors Involved in Extracellular Matrix Turnover in Human Derived Cardiomyocytes. Cellular Physiology and Biochemistry. 32(5). 1125–1136. 11 indexed citations
9.
Reichenbach, Vedrana, Guillermo Fernández‐Varo, Gregori Casals, et al.. (2012). Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats. Journal of Hepatology. 57(5). 967–973. 25 indexed citations
10.
Melgar‐Lesmes, Pedro, Montse Pauta, Vedrana Reichenbach, et al.. (2011). Hypoxia and proinflammatory factors upregulate apelin receptor expression in human stellate cells and hepatocytes. Gut. 60(10). 1404–1411. 56 indexed citations
11.
Segovia‐Silvestre, Toni, Vedrana Reichenbach, Guillermo Fernández‐Varo, et al.. (2011). Circulating CO3-610, a degradation product of collagen III, closely reflects liver collagen and portal pressure in rats with fibrosis. PubMed. 4(1). 19–19. 28 indexed citations
12.
Reichenbach, Vedrana, Josefa Ros Velasco, Guillermo Fernández‐Varo, et al.. (2011). Prevention of Fibrosis Progression in CCl4-Treated Rats: Role of the Hepatic Endocannabinoid and Apelin Systems. Journal of Pharmacology and Experimental Therapeutics. 340(3). 629–637. 54 indexed citations
13.
Fernández‐Varo, Guillermo, Vedrana Reichenbach, Josefa Ros Velasco, et al.. (2011). 599 TRANSDUCTION OF ADENOVIRUS ENCODING DOMINANT-NEGATIVE SOLUBLE PDGFRβ IMPROVES SYSTEMIC HEMODYNAMICS, PORTAL PRESSURE AND HEPATIC FIBROSIS IN RATS CHRONICALLY TREATED WITH CCL4. Journal of Hepatology. 54. S243–S243. 1 indexed citations
14.
Melgar‐Lesmes, Pedro, Gregori Casals, Montse Pauta, et al.. (2010). Apelin Mediates the Induction of Profibrogenic Genes in Human Hepatic Stellate Cells. Endocrinology. 151(11). 5306–5314. 53 indexed citations
15.
Reichenbach, Vedrana, Josefa Ros Velasco, & Wladimiro Jiménez. (2009). Cannabinoides endógenos en la enfermedad hepática: muchos dardos para una sola diana. Gastroenterología y Hepatología. 33(4). 323–329. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordi Ribera Breakdown of academic impact, for papers by Hans Ernst Breakdown of academic impact, for papers by Tadahiro Shinozawa Breakdown of academic impact, for papers by Vaishaali Natarajan Breakdown of academic impact, for papers by Sayuri Nakamura Breakdown of academic impact, for papers by Xiaojun Cai Breakdown of academic impact, for papers by Qinglin Zhang Breakdown of academic impact, for papers by Dina H. Kassem Breakdown of academic impact, for papers by Yiming Liu Breakdown of academic impact, for papers by Fen Zhang
Rankless by CCL
2026